TY - JOUR
T1 - The risk of psychosis for transgender individuals
T2 - A Dutch national cohort study
AU - Termorshuizen, Fabian
AU - de Vries, Annelou L. C.
AU - Wiepjes, Chantal M.
AU - Selten, Jean-Paul
N1 - Funding Information: Fabian Termorshuizen is also employed at the Amsterdam UMC, Department of Medical Informatics and receives funding from the National Intensive Care Evaluation Foundation (Stichting NICE). There are no conflicts of interest for other authors. Funding Information: This research was supported by the J.M.C. Kaptein Foundation. Publisher Copyright: Copyright © The Author(s), 2023. Published by Cambridge University Press.
PY - 2023/12/4
Y1 - 2023/12/4
N2 - Background The stressful minority position of transgender persons may result in a high risk of psychosis. Conflicting data suggest that the observed risk depends on setting of recruitment. We assessed the relative risk of non-affective psychotic disorder (NAPD) in a large, representative cohort of transgender persons. Methods This cohort was composed using: data on legal sex change from the Dutch population registry and data on dispensing of cross-sex hormones (route 1), and a registry of insurance claims from mental health care including persons with a diagnosis of gender identity disorder (DSM-IV) or gender dysphoria (DSM-5) (route 2). They were matched by sex at birth, calendar year and country of birth to controls from the general population. Transgender persons (N = 5564) and controls (N = 27 820), aged 16-60 years at 1 January 2011, were followed until the first insurance claim for NAPD in 2011-2019. Results The incidence rate ratio (IRR) of NAPD for transgender persons selected exclusively through route 1 (N = 3859, IRR = 2.00, 95%-CI 1.52-2.63) was increased, but significantly lower than the IRRs for those selected exclusively through route 2 (N = 694, IRR = 22.15, 95%-CI 13.91-35.28) and for those found by both routes (N = 1011, IRR = 5.17, 95%-CI 3.57-7.49; p value for differences in IRR < 0.001). Conclusions This study supports the social defeat-hypothesis of NAPD. The results also show the presence of a substantial number of transgender persons with severe psychiatric problems who have not (yet) taken steps to gender-affirmative care.
AB - Background The stressful minority position of transgender persons may result in a high risk of psychosis. Conflicting data suggest that the observed risk depends on setting of recruitment. We assessed the relative risk of non-affective psychotic disorder (NAPD) in a large, representative cohort of transgender persons. Methods This cohort was composed using: data on legal sex change from the Dutch population registry and data on dispensing of cross-sex hormones (route 1), and a registry of insurance claims from mental health care including persons with a diagnosis of gender identity disorder (DSM-IV) or gender dysphoria (DSM-5) (route 2). They were matched by sex at birth, calendar year and country of birth to controls from the general population. Transgender persons (N = 5564) and controls (N = 27 820), aged 16-60 years at 1 January 2011, were followed until the first insurance claim for NAPD in 2011-2019. Results The incidence rate ratio (IRR) of NAPD for transgender persons selected exclusively through route 1 (N = 3859, IRR = 2.00, 95%-CI 1.52-2.63) was increased, but significantly lower than the IRRs for those selected exclusively through route 2 (N = 694, IRR = 22.15, 95%-CI 13.91-35.28) and for those found by both routes (N = 1011, IRR = 5.17, 95%-CI 3.57-7.49; p value for differences in IRR < 0.001). Conclusions This study supports the social defeat-hypothesis of NAPD. The results also show the presence of a substantial number of transgender persons with severe psychiatric problems who have not (yet) taken steps to gender-affirmative care.
KW - Epidemiology
KW - minority stress
KW - psychotic disorder
KW - social defeat
KW - transgender persons
UR - http://www.scopus.com/inward/record.url?scp=85167406125&partnerID=8YFLogxK
U2 - https://doi.org/10.1017/S0033291723002088
DO - https://doi.org/10.1017/S0033291723002088
M3 - Article
C2 - 37539460
SN - 0033-2917
VL - 53
SP - 7923
EP - 7932
JO - Psychological Medicine
JF - Psychological Medicine
IS - 16
ER -